跳至主要内容
临床试验/ACTRN12615000503527
ACTRN12615000503527已完成未知

A study to determine periostin as a predictor of severe exacerbations in asthma in adult asthmatics

Medical Research Institute of New Zealand0 个研究点目标入组 230 人开始时间: 2015年5月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
230

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 95 Years(—)
性别
All

入选标准

  • Participants from:
  • -New Zealand Respiratory Health Survey (NZRHS) (ACTR number 12610000666022) phase two and
  • -Longitudinal study of serum periostin levels in asthma (PER02)(ACTR number 12614000235606)
  • Able to perform written informed consent

排除标准

  • -Known pregnancy
  • -Surgery within last 3 months, determined at investigator discretion (this includes all major surgery requiring general anaesthetic, dental extractions and root canal procedures. This does not include minor procedures including, but not limited to, mole or wart removal, dental fillings etc)
  • -Bone fracture within last 3 months
  • -Active (current, or within the 3 weeks prior to the visit) upper or lower respiratory tract infection
  • -Any other safety concern at the investigator's discretion

研究者

相似试验

Periostin as a predictor of severe exacerbations in... | 临床试验